Yongbo Peng - Search Results

Year	Number of Results
2008	2
2009	3
2010	4
2011	2
2012	3
2013	5
2014	1
2015	2
2016	4
2017	10
2018	14
2019	15
2020	15
2021	10
2022	10
2023	14
2024	5

1

PARP inhibitor veliparib and HDAC inhibitor SAHA synergistically co-target the UHRF1/BRCA1 DNA damage repair complex in prostate cancer cells.

Yin L, Liu Y, Peng Y, Peng Y, Yu X, Gao Y, Yuan B, Zhu Q, Cao T, He L, Gong Z, Sun L, Fan X, Li X. Yin L, et al. Among authors: peng y. J Exp Clin Cancer Res. 2018 Jul 16;37(1):153. doi: 10.1186/s13046-018-0810-7. J Exp Clin Cancer Res. 2018. PMID: 30012171 Free PMC article.

2

Engineered Selenium/Human Serum Albumin Nanoparticles for Efficient Targeted Treatment of Parkinson's Disease via Oral Gavage.

Xu K, Huang P, Wu Y, Liu T, Shao N, Zhao L, Hu X, Chang J, Peng Y, Qu S. Xu K, et al. Among authors: peng y. ACS Nano. 2023 Oct 24;17(20):19961-19980. doi: 10.1021/acsnano.3c05011. Epub 2023 Oct 8. ACS Nano. 2023. PMID: 37807265 Free PMC article.

3

A basic insight into aptamer-drug conjugates (ApDCs).

Xuan W, Peng Y, Deng Z, Peng T, Kuai H, Li Y, He J, Jin C, Liu Y, Wang R, Tan W. Xuan W, et al. Among authors: peng y. Biomaterials. 2018 Nov;182:216-226. doi: 10.1016/j.biomaterials.2018.08.021. Epub 2018 Aug 8. Biomaterials. 2018. PMID: 30138784 Review.

4

A Great late Ediacaran ice age.

Wang R, Shen B, Lang X, Wen B, Mitchell RN, Ma H, Yin Z, Peng Y, Liu Y, Zhou C. Wang R, et al. Among authors: peng y. Natl Sci Rev. 2023 Apr 25;10(8):nwad117. doi: 10.1093/nsr/nwad117. eCollection 2023 Aug. Natl Sci Rev. 2023. PMID: 37389143 Free PMC article.

5

Targeting treatment of bladder cancer using PTK7 aptamer-gemcitabine conjugate.

Xiang W, Peng Y, Zeng H, Yu C, Zhang Q, Liu B, Liu J, Hu X, Wei W, Deng M, Wang N, Liu X, Xie J, Hou W, Tang J, Long Z, Wang L, Liu J. Xiang W, et al. Among authors: peng y. Biomater Res. 2022 Dec 5;26(1):74. doi: 10.1186/s40824-022-00328-9. Biomater Res. 2022. PMID: 36471380 Free PMC article.

6

Anticancer agents derived from natural products.

Liu EH, Qi LW, Wu Q, Peng YB, Li P. Liu EH, et al. Mini Rev Med Chem. 2009 Nov 1;9(13):1547-55. doi: 10.2174/138955709790361520. Mini Rev Med Chem. 2009. PMID: 20205636 Review.

7

Broad targeting of triptolide to resistance and sensitization for cancer therapy.

Hou ZY, Tong XP, Peng YB, Zhang BK, Yan M. Hou ZY, et al. Biomed Pharmacother. 2018 Aug;104:771-780. doi: 10.1016/j.biopha.2018.05.088. Epub 2018 May 29. Biomed Pharmacother. 2018. PMID: 29807227 Review.

8

The biological function of metazoan-specific subunit nuclear factor related to kappaB binding protein of INO80 complex.

Peng Q, Wan D, Zhou R, Luo H, Wang J, Ren L, Zeng Y, Yu C, Zhang S, Huang X, Peng Y. Peng Q, et al. Among authors: peng y. Int J Biol Macromol. 2022 Apr 1;203:176-183. doi: 10.1016/j.ijbiomac.2022.01.155. Epub 2022 Jan 29. Int J Biol Macromol. 2022. PMID: 35093437 Review.

9

Triggering Receptor Expressed on Myeloid Cells-1 Signaling: Protective and Pathogenic Roles on Streptococcal Toxic-Shock-Like Syndrome Caused by Streptococcus suis.

Han L, Fu L, Peng Y, Zhang A. Han L, et al. Among authors: peng y. Front Immunol. 2018 Mar 21;9:577. doi: 10.3389/fimmu.2018.00577. eCollection 2018. Front Immunol. 2018. PMID: 29619033 Free PMC article. Review.

10

Anti-diabetic agents from natural products--an update from 2004 to 2009.

Qi LW, Liu EH, Chu C, Peng YB, Cai HX, Li P. Qi LW, et al. Curr Top Med Chem. 2010;10(4):434-57. doi: 10.2174/156802610790980620. Curr Top Med Chem. 2010. PMID: 20180758 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

105 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

105 results

Results by year